Gour Medical History

January 9, 2018

Focus on medical cannabis for companion animals

July 5, 2017

Transfer of the corporate headquarter to France

December 1, 2016

GOUR Medical, animal health specialist, lists on the Marché Libre Euronext Paris

March 15, 2016

Gour Medical SA signs an exclusive manufacturing, distribution and marketing agreement with the UK company Medicom Healthcare Limited for the marketing of high-quality ophthalmic products for pets.

December 12, 2015

Gour Medical SA signs an exclusive licensing agreement with world leader in animal health diagnostics: Idexx Laboratories Inc. (NASDAQ: IDXX) for the development of an anti-IgE monoclonal antibody to treat atopic dermatitis in dogs.

November 24, 2015

Gour Medical SA signs an exclusive worldwide license, manufacturing, distribution and service agreement with the German company Solmic Research GmbH, specializing in innovative systems for the development of products based on natural cannabinoids.

March 5, 2015

Gour Medical SA signs an exclusive worldwide licensing agreement with the Swiss pharmaceutical company Actelion (SIX : ATLN) for Gour-713, an Orexine receptor antagonist to treat stress and anxiety in pets.

July 14, 2014

Gour Medical SA created in Switzerland in the canton of Zug with a capital of CHF 100,000

Gour Medical in the news